Mergers & Acquisitions Mergers & Acquisitions

Illumina tells EU judges it and Grail were ‘used as guinea pigs’ for new referral rules

Illumina told EU judges today that the European Commission had no right to seize jurisdiction over its acquisition of cancer-testing company Grail, and ran roughshod over its procedural rights.

The US gene-sequencing company was at the EU General Court to challenge the commission’s acceptance of a referral request from France, which

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Natalie McNelis

Senior Correspondent


Natalie McNelis covers mergers for MLex in Brussels. Before joining MLex in 2017, she spent 20 years as an international trade and competition lawyer in law firms including Stibbe and WilmerHale. Natalie has a BA in English from Mount Holyoke College, a JD from Harvard Law School and an LLM in EU law from KU Leuven. She is admitted to the bar in New York.

Discover MLex

Stay on top of global regulatory developments

TAKE A FREE TRIAL

Latest News